Olink to Science

How proteomics using Olink helped advance diabetic kidney disease research

Aug 2, 2021 9:30:00 AM / by Olink posted in Metabolic diseases, Nephrology, Biomarkers, Clinical research, Proteomics


Dr. Andrzej Krolewski (Find his profile here), the head of the Genetics and Epidemiology section of the Harvard Medical School, has been working on the genetics of type 1 and type 2 diabetes. For the last 30 years, he has been actively investigating diabetic kidney disease in patient cohorts from the Joslin diabetes center, where he is also a researcher.

Read More